Sign inJoin waitlistJoin the waitlist

SL

Stuart Lessin

Physician · Duke University Hospital

Credentials: · ·

History

Duke University Hospital
Present

Dermatology

Research

Clinical end points and response criteria in mycosis fungoides and Sézary syndrome: a consensus statement of the International Society for Cutaneous Lymphomas, the United States…
Journal of Clinical Oncology · 2011 · 548 citations
Subcutaneous panniculitis-like T-cell lymphoma: clinicopathologic, immunophenotypic, and genotypic analysis of alpha/beta and gamma/delta subtypes
Case report · The American Journal of Surgical Pathology · 1998 · 232 citations
Th2 cytokine mRNA expression in skin in cutaneous T-cell lymphoma
Journal of Investigative Dermatology · 1994 · 223 citations

Alain Rook
33 papers · 4 as a fellow
EV
Eric Vonderheid
18 papers
Hong Wu
11 papers
JW
Jonathan Wolfe
8 papers · 5 as a resident
CJ
Christine Jaworsky
6 papers
Rosalie Elenitsas
6 papers
Gary Wood
5 papers
Mariusz Wasik
4 papers
Michael Ming
4 papers
Peter Nowell
4 papers
AO
Allan Oseroff
3 papers
Ashok Shaha
3 papers

Grants

A Phase II Pivotal Trial to Evaluate the Safety and Efficacy of Notrogen Mustard
Food and Drug Administration · R01
Contact PI · $1.5M · Fox Chase Cancer Center
2006–2010
Patient Oriented Research in Cutaneous Oncology
National Institute of Arthritis and Musculoskeletal and Skin Diseases · K24
Contact PI · $587.2K · Fox Chase Cancer Center
1999–2005
Abramson Cancer Center Support Grant
National Cancer Institute · P30
Project lead · $1M · University of Pennsylvania
2000–2002
Molecular Characterization of Cutaneous t Cell Lymphoma
National Cancer Institute · R29
Contact PI · $506.7K · University of Pennsylvania
1991–1996

Clinical trials

Evaluation of the Efficacy and Tolerance of a Light Therapy Mask on Mild to Moderate Brown Spots and Moderate to Severe Facial Wrinkles
Principal investigator · Completed
Johnson & Johnson Consumer Inc. (J&JCI)
2017–2018
BPX-01 Minocycline 1% Topical Gel for Reduction of Propionibacterium Acnes
Principal investigator · Completed · Phase 2
BioPharmX, Inc.
2016
Administration of Oral Extended Release Minocycline for Assessment of Skin and Plasma Concentrations of Minocycline
Principal investigator · Completed · Phase 4
BioPharmX, Inc.
2016
A Phase 1 Study Assessing Local Cutaneous Effects of SB204
Principal investigator · Completed · Phase 1
Novan, Inc.
2014